Back
Range Cancer Therapeutics ETF Vs. Concentrix Industry Stock Comparison
Sell
38
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.92
Seasonality Move:
-2.75%
Sell
29
CNXC
Concentrix
Last Price:
51.56
Seasonality Move:
18.02%
Sell
38
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.94. The Score for CNCR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Concentrix (CNXC)
is a Sell
Is Concentrix a Buy, Sell or Hold?
- The current Concentrix [CNXC] share price is $51.56. The Score for CNXC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- CNXC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.94
The current trend is moderately bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNXC Stock Price Chart
What is Concentrix's stock price today?
-
The Concentrix share price today is $51.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNXC is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 48 | Sell |
Chaikin Money Flow: | 1445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.66 - 15.58) | Sell |
Bollinger Bands (100): | (13.97 - 15.37) | Buy |
CNXC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.55 | Sell |
Relative Strength Index (14 RSI): | 18.65 | Sell |
Chaikin Money Flow: | -4472771 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.94 - 73.92) | Sell |
Bollinger Bands (100): | (60.76 - 69.64) | Sell |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.31 | Sell |
20-day SMA: | 15.15 | Sell |
50-day SMA: | 14.83 | Buy |
200-day SMA: | 14.82 | Buy |
8-day EMA: | 15.19 | Sell |
20-day EMA: | 15.15 | Sell |
50-day EMA: | 14.91 | Buy |
200-day EMA: | 14.47 | Buy |
CNXC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.31 | Sell |
20-day SMA: | 67.73 | Sell |
50-day SMA: | 67.46 | Sell |
200-day SMA: | 71.37 | Sell |
8-day EMA: | 61.71 | Sell |
20-day EMA: | 65.26 | Sell |
50-day EMA: | 66.53 | Sell |
200-day EMA: | 71.15 | Sell |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Concentrix Earnings Growth & CNXC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.36 per share, an increase this year of $0.11 per share, and an increase next year of $1.31 per share.
Range Cancer Therapeutics ETF Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Concentrix Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |